NCT02094430View on ClinicalTrials.gov

Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Hypofibrinogenemia, CongenitalAfibrinogenemia, Congenital
Interventions
DRUG

biological: human fibrinogen concentrate

Trial Locations (4)

75015

Hopital Necker enfants malades, Paris

Unknown

Hôpital Hôtel Dieu, Beirut

Hôpital d'enfants - CHU Avicenne, Rabat

Faculty Ihsan Dogramaci Children's Hospital, Ankara

All Listed Sponsors
lead

Laboratoire français de Fractionnement et de Biotechnologies

INDUSTRY

NCT02094430 - Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency | Biotech Hunter | Biotech Hunter